
Top Stories 
Published On July 23, 2011
CLINICAL RESEARCH
Sleep, Interrupted
Repeatedly waking up costs sufferers not only a good night’s rest, but their health and money as well.
18 million
Estimated number of Americans who suffer from sleep apnea, a disorder characterized by brief interruptions of breathing that can occur 20 or more times per hour; the combination of intermittent oxygen drops and reduced sleep quality triggers the release of stress hormones, which in turn raise blood pressure and heart rate, boosting the risk of heart attack, stroke and congestive heart failure
2
Main types: obstructive sleep apnea, the more common, in which relaxation of throat muscles and often a narrow airway leads to pauses in breathing; and central sleep apnea, a rare form in which the brain doesn’t send proper signals to the muscles that control breathing
80
Estimated percentage of people with obstructive sleep apnea who remain undiagnosed
2
Times more likely that people with sleep apnea suffer from hypertension
2–7
Times more likely that untreated sleep apnea increases the risk of vehicle crashes
5
Estimated percentage of weight loss that can help reduce the occurrence of sleep apnea in overweight people, for whom this disorder is more common (fat deposits around the upper airway may obstruct breathing)
$150
Low-end cost of one of the most effective treatments: a continuous positive airway device, which holds the airway open by delivering pressurized air through a mask
30–60
Percent success rate for patients who receive uvulopalatopharyngoplasty surgery to remove excess tissue in the back of the throat
Dispatches

One Thing Leads to the Next Robert Lefkowitz is best known for revealing the mechanism behind hundreds of drugs in use today. But he thinks of himself as a storyteller first and has a new book out to make his case.

Podcast: The Research Year That Was Medical research labs have faced a difficult stretch of closed buildings and competing priorities. Yet they have also produced milestone discoveries—and not only on COVID-19.

The Shape of Us Two milestone discoveries in protein modeling promise to change the fundamentals of drug discovery.

Universal Flu Vaccines Move Forward In the shadow of coronavirus vaccine development, another vaccine was making solid progress.

New Hope for Controlling HIV By studying elite controllers—people who are able to arrest the progress of HIV without medication—researchers have found a promising new path.

Progress on a Different Plague A novel use of bacteria could blunt the spread of dengue and other mosquito-borne diseases.

A Better Cholera Vaccine? Puzzling through the cholera antibody response may help slow a disease that affects millions of people every year.

Top Stories 

The Neuroscience of Giving Up
Why do some people react poorly, even catastrophically, in emergency situations?